Anti-Human CD20 Therapeutic Antibody

1. Ofatumumab (TAB-028) DESCRIPTION CATALOG # SIZE Anti-Human CD20 Therapeutic Antibody (Arzerra) TAB-028 1mg PRODUCT INFORMATION Product Overview Recombinant monoclonal antibody to Human CD20. Ofatumumab (trade name Arzerra, also known as HuMax-CD20) is a human monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab (Campath) and has also shown potential in treating Follicular non- Hodgkin's lymphoma, Diffuse large B cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis. Ofatumumab has also received conditional approval in Europe for the treatment of refractory chronic lymphocytic leukemia. This makes ofatumumab the first marketing application for an antibody, as well as the first human monoclonal antibody which targets the CD20 molecule that will be available for patients with refractory CLL. Target CD20 Type IgG1 - kappa Immunogen Hmuan CD20 transfected NS/O cells. Species Reactivity Human Expression Host CHO Applications Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.                            

2. CAS 679818-59-8 Trade name arzerra Specificity Tested positive against native human antigen Predicted N terminal H Chain: MFLGLSWL Chain: MEAPAQL Purity >95.0%. Determined by analysis by RP-HPLC & analysis by SDS-PAGE. Size 1mg Storage 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.                             BACKGROUND Antigen Description CD20 is B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells. Function epidermal growth factor receptor binding; Gene ID 931 Synonyms MS4A1; membrane-spanning 4-domains, subfamily A, member 1; CD20; B- lymphocyte antigen CD20; B1; Bp35; MS4A2; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1; S7; CVID5; LEU-16; MGC3969;                 Related Products TAB-722 Anti-IFNAR Therapeutic Antibody TAB-735      

3. Anti-Influenza A hemagglutinin Therapeutic Antibody TAB-021 Anti-Human IL1Beta Therapeutic Antibody (Ilaris) TAB-H72 Anti-Human CXCR4 Therapeutic Antibody TAB-040 Anti-Human EGFR Therapeutic Antibody (HuMax-EGFr) TAB-069 Anti-Human IL17A Therapeutic Antibody TAB-100 Anti-Human TGF beta 2 Therapeutic Antibody TAB-067 Anti-Human CTLA4 Therapeutic Antibody (Yervoy) TAB-119 Anti-Human EGFR Therapeutic Antibody TAB-209 Anti-Human IGF1 Receptor Therapeutic Antibody                                  